MA26648A1 - Associations thérapeutiques pour le traitement de maladies osseuses, et procédé pour leur préparation. - Google Patents

Associations thérapeutiques pour le traitement de maladies osseuses, et procédé pour leur préparation.

Info

Publication number
MA26648A1
MA26648A1 MA25622A MA25622A MA26648A1 MA 26648 A1 MA26648 A1 MA 26648A1 MA 25622 A MA25622 A MA 25622A MA 25622 A MA25622 A MA 25622A MA 26648 A1 MA26648 A1 MA 26648A1
Authority
MA
Morocco
Prior art keywords
preparation
treatment
bone diseases
therapeutic combinations
therapeutic
Prior art date
Application number
MA25622A
Other languages
English (en)
Inventor
Zhu Ke Hua
Li Mei
Codetta Pan Lydia
Duane Thompson David
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MA26648A1 publication Critical patent/MA26648A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
MA25622A 1998-06-16 1999-06-15 Associations thérapeutiques pour le traitement de maladies osseuses, et procédé pour leur préparation. MA26648A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8942498P 1998-06-16 1998-06-16

Publications (1)

Publication Number Publication Date
MA26648A1 true MA26648A1 (fr) 2004-12-20

Family

ID=22217565

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25622A MA26648A1 (fr) 1998-06-16 1999-06-15 Associations thérapeutiques pour le traitement de maladies osseuses, et procédé pour leur préparation.

Country Status (29)

Country Link
EP (1) EP1085867A1 (fr)
JP (1) JP2002518328A (fr)
KR (1) KR20010052817A (fr)
CN (1) CN1305378A (fr)
AP (1) AP9901581A0 (fr)
AR (1) AR018868A1 (fr)
AU (1) AU3342099A (fr)
BG (1) BG105128A (fr)
BR (1) BR9911357A (fr)
CA (1) CA2335112A1 (fr)
CO (1) CO5070586A1 (fr)
EA (1) EA200001189A1 (fr)
GT (1) GT199900083A (fr)
HR (1) HRP20000857A2 (fr)
HU (1) HUP0102395A2 (fr)
ID (1) ID26726A (fr)
IL (1) IL139587A0 (fr)
IS (1) IS5727A (fr)
MA (1) MA26648A1 (fr)
NO (1) NO20006381D0 (fr)
OA (1) OA11569A (fr)
PA (1) PA8472101A1 (fr)
PE (1) PE20000633A1 (fr)
PL (1) PL345064A1 (fr)
SK (1) SK18902000A3 (fr)
TN (1) TNSN99118A1 (fr)
UY (1) UY25557A1 (fr)
WO (1) WO1999065488A1 (fr)
ZA (1) ZA993973B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004306A3 (fr) * 1998-08-06 2000-06-07 Pfizer Products Inc. Agonistes/antagonistes de l'estrogène
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
CA2420535A1 (fr) * 2000-08-30 2002-03-07 Mary Tanya Am Ende Formulations a liberation prolongee pour les secretagogues de l'hormone de croissance
US7524866B2 (en) 2001-11-29 2009-04-28 Gtx, Inc. Prevention and treatment of androgen—deprivation induced osteoporosis
DK1460969T3 (da) * 2001-11-29 2008-09-01 Gtx Inc Forebyggelse og behandling af ved androgen-berövelse fremkaldt osteoporose
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
EP2118080B1 (fr) 2007-02-09 2016-08-31 Ocera Therapeutics, Inc. Modulateurs macrocycliques du récepteur de la ghréline et leurs procédés d'utilisation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
AP9901581A0 (en) 1999-06-30
CN1305378A (zh) 2001-07-25
EP1085867A1 (fr) 2001-03-28
CO5070586A1 (es) 2001-08-28
BR9911357A (pt) 2001-03-13
HUP0102395A2 (hu) 2001-11-28
AR018868A1 (es) 2001-12-12
AU3342099A (en) 2000-01-05
ID26726A (id) 2001-02-01
PE20000633A1 (es) 2000-07-26
HRP20000857A2 (en) 2001-10-31
OA11569A (en) 2004-07-01
IL139587A0 (en) 2002-02-10
UY25557A1 (es) 2001-01-31
EA200001189A1 (ru) 2001-06-25
NO20006381L (no) 2000-12-14
PL345064A1 (en) 2001-11-19
CA2335112A1 (fr) 1999-12-23
GT199900083A (es) 2000-12-05
PA8472101A1 (es) 2000-09-29
JP2002518328A (ja) 2002-06-25
TNSN99118A1 (fr) 2005-11-10
SK18902000A3 (sk) 2001-12-03
KR20010052817A (ko) 2001-06-25
WO1999065488A1 (fr) 1999-12-23
BG105128A (en) 2001-11-30
IS5727A (is) 2000-11-24
ZA993973B (en) 2000-12-15
NO20006381D0 (no) 2000-12-14

Similar Documents

Publication Publication Date Title
HUP9700603A3 (en) Pharmaceutical preparation for the treatment of blood coagulation disorders
NO963568D0 (no) Farmasöytisk preparat for behandling av blodkoagulasjonssykdommer, fremgangsmåter for fremstilling av dette og dets anvendelse
MA26420A1 (fr) Compositions pharmaceutiques mixtes pour le traitement de l'osteoporose, et procede pour leur preparation.
DE60023043T2 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
AU2732001A (en) Apparatus and method of treatment of wounds, burns and immune system disorders
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
AU1227302A (en) System and method for optimizing drug therapy for the treatment of diseases
FR2707882B1 (fr) Nouveaux kits thérapeutiques anti-médiateurs protéiques, procédé de préparation et compositions pharmaceutiques les renfermant.
FI952169A0 (fi) Stabiili valmiste veren koagulaatiohäiriöiden hoitamiseksi
ATE201992T1 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
EP0376251A3 (en) An anticoagulant substance obtained from urine
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
MA26648A1 (fr) Associations thérapeutiques pour le traitement de maladies osseuses, et procédé pour leur préparation.
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
WO1999056666A8 (fr) Traitement des troubles de la sexualite chez certains groupes de patients
FR2725990B1 (fr) Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
TR200200278T2 (tr) Kalsilitik bileşimler
DZ3225A1 (fr) Methode et compositions pour le traitement des maladies pulmonaires
MA26650A1 (fr) Oxo-thia -azabicyclooctenes, preparations pharmaceutiques les contenant, et leur utilisation pour le traitement et la prophylaxie de maladies infectieuses.
MA26652A1 (fr) Compositions pharmaceutiques mixtes pour le traitement de la faiblesse musculosquelettique, et procede pour leur preparation
DZ2544A1 (fr) Formes posologiques de sertraline et procédé pour leur préparation.
DE69739190D1 (de) Arzneimittel zur behandlung von oculären kreislauferkrankungen